NCT02272790 2023-10-03Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerAstraZenecaPhase 2 Completed95 enrolled 61 charts